← Leaderboards
Shengyun Fang
University Of Md Biotechnology Institute
$4,451,264
Attributed
$4,451,264
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $455.9K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,451,264 · 4
By mechanism
U01$2,601,056 · 2
R01$1,447,271 · 1
R21$402,937 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Md Biotechnology Institute
Same institution · by research overlap
- Michael K. Gilson$22,308,704
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsMutantMediatingCellsReportingEndoplasmic ReticulumProteinsUbiquitin-Protein LigasePathogenesisCellular BiologyMolecular ConformationMisfolded ProteinSignal TransductionUbiquitinLinkPharmaceutical PreparationsPublic Health RelevanceBindingCo-ImmunoprecipitationsBaseIn VitroProtein ExpressionCystic FibrosisStress
Grant awards (16)
Pharmacologic enhancement of UBA1 activity in models of VEXAS syndrome$355,106
U01 · FY2025 · AR · contact PI
Pharmacologic enhancement of UBA1 activity in models of VEXAS syndrome$394,562
U01 · FY2024 · AR · contact PI
Pharmacologic enhancement of UBA1 activity in models of VEXAS syndrome$394,562
U01 · FY2023 · AR · contact PI
Pharmacologic enhancement of UBA1 activity in models of VEXAS syndrome$394,562
U01 · FY2022 · AR · contact PI
High-Content Screening to identify small molecules for refolding SOD1 mutants$303,206
U01 · FY2019 · GM · contact PI
High-Content Screening to Identify Small Molecules for Refolding SOD1 Mutants$152,645
U01 · FY2019 · GM · contact PI
High-Content Screening to identify small molecules for refolding SOD1 mutants$303,206
U01 · FY2018 · GM · contact PI
High-Content Screening to identify small molecules for refolding SOD1 mutants$303,207
U01 · FY2017 · GM · contact PI
ER stress in ethanol-induced injury to hepatocytes$220,656
R21 · FY2016 · AA · contact PI
ER stress in ethanol-induced injury to hepatocytes$182,281
R21 · FY2015 · AA · contact PI
Novel functions for gp78 in ER-associated degradation$278,610
R01 · FY2008 · GM · contact PI
Novel functions for gp78 in ER-associated degradation$3,030
R01 · FY2008 · GM · contact PI
Novel functions for gp78 in ER-associated degradation$281,610
R01 · FY2007 · GM · contact PI
Novel functions for gp78 in ER-associated degradation$290,021
R01 · FY2006 · GM · contact PI
Novel functions for gp78 in ER-associated degradation$297,000
R01 · FY2005 · GM
Novel functions for gp78 in ER-associated degradation$297,000
R01 · FY2004 · GM